166 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
the Revised Exercise Period, the Board may determine that the Revised Exercise Period shall be reduced.
(f)Employee Benefits. During the Employment Period … , Executive shall be entitled to participate in all of the Company’s then-existing employee benefit programs for which senior executive employees
8-K
6qh2238mu74f8um
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
S-8
EX-5.1
aoe50897i cx0
30 Nov 23
Registration of securities for employees
4:16pm
S-8
i1213wuzs 6hmd
30 Nov 23
Registration of securities for employees
4:16pm
S-8
cbvzot
30 Nov 23
Registration of securities for employees
4:16pm
S-8 POS
xpvoaj
29 Jun 23
Registration of securities for employees (post-effective amendment)
4:54pm
S-8 POS
zt53 byp56vkjv
29 Jun 23
Registration of securities for employees (post-effective amendment)
4:48pm
8-K
EX-10.2
cb89sez57byn xpnuq
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
3zs7j0
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
80t1 86h872vhoi0i4ng
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.3
y5yesk5xue2 c71h30cu
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.1
l9ijw6c6sq9 po7t
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.4
2t4 hsxcrkyqbwyk
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.2
u4ctg9p
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm